Should I buy or sell Azenta stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AZTA shares. View AZTA analyst ratings or view top-rated stocks .

What is Azenta's stock price target for 2024?

4 Wall Street analysts have issued 1 year target prices for Azenta's shares. Their AZTA share price targets range from $55.00 to $68.00. On average, they anticipate the company's share price to reach $63.67 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price. View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts .

How have AZTA shares performed in 2023?

Azenta's stock was trading at $58.22 at the start of the year. Since then, AZTA stock has decreased by 1.1% and is now trading at $57.60. View the best growth stocks for 2023 here .

When is Azenta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024. View our AZTA earnings forecast .

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) released its quarterly earnings data on Monday, November, 13th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.12. The company earned $165.95 million during the quarter, compared to analyst estimates of $163.91 million. Azenta had a negative net margin of 2.14% and a positive trailing twelve-month return on equity of 0.75%. The business's revenue was up 25.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.16 earnings per share.

Is Azenta a good dividend stock?

Azenta (NASDAQ:AZTA) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for AZTA .

What ETFs hold Azenta's stock?

ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC) , ROBO Global Robotics & Automation ETF (ROBO) , Harbor Health Care ETF (MEDI) and Principal Healthcare Innovators ETF (BTEC) . BlackRock Future Innovators ETF (BFTR) .

What guidance has Azenta issued on next quarter's earnings?

Azenta updated its FY 2024 earnings guidance on Monday, November, 13th. The company provided earnings per share guidance of $0.19-$0.29 for the period, compared to the consensus earnings per share estimate of $0.22. The company issued revenue guidance of $696.00 million-$718.00 million, compared to the consensus revenue estimate of $705.60 million.

Who are Azenta's major shareholders?

Azenta's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (7.53%), Allspring Global Investments Holdings LLC (3.02%), Teacher Retirement System of Texas (1.91%), Conestoga Capital Advisors LLC (1.89%), JPMorgan Chase & Co. (1.85%) and Morgan Stanley (1.78%). Insiders that own company stock include David C Gray , Jesus Linda De , Kimberly Crowley , Lindon G Robertson and Matthew Mcmanus. View institutional ownership trends .

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Azenta Stock Price, News & Analysis (NASDAQ:AZTA)

$57.60

-0.64 (-1.10%)

(As of 12/8/2023 ET)

Compare

Today's Range: $57.32
▼
$58.70
50-Day Range: $44.02
▼
$58.32
52-Week Range: $36.01
▼
$63.60

Volume: 282,404 shs
Average Volume: 953,934 shs
Market Capitalization: $3.23 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $63.67

Azenta MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 10.5% Upside
$63.67 Price Target
Short Interest: Bearish
9.94% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 144.44%
From $0.27 to $0.66 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars

Medical Sector

711th out of 954 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

9th out of 13 stocks

2.3

Analyst's Opinion

Consensus Rating
Azenta has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $63.67, Azenta has a forecasted upside of 10.5% from its current price of $57.60.
Amount of Analyst Coverage
Azenta has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
9.94% of the float of Azenta has been sold short.
Short Interest Ratio / Days to Cover
Azenta has a short interest ratio ("days to cover") of 7.7.
Change versus previous month
Short interest in Azenta has recently decreased by 1.80%, indicating that investor sentiment is improving.

0.8

Dividend Strength

Dividend Yield
Azenta does not currently pay a dividend.
Dividend Growth
Azenta does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Azenta will have a dividend payout ratio of 15.15% next year. This indicates that Azenta will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AZTA.

1.1

News and Social Media Coverage

Search Interest
5 people have searched for AZTA on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
MarketBeat Follows
5 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Azenta insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.67% of the stock of Azenta is held by insiders.
Percentage Held by Institutions
99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Azenta are expected to grow by 144.44% in the coming year, from $0.27 to $0.66 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Azenta is -319.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Azenta is -319.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Azenta has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AZTA Stock News Headlines

November 21, 2023 | finance.yahoo.com

Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference

November 16, 2023 | finance.yahoo.com

Politan Capital Management LP Bolsters Stake in Azenta Inc

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 14, 2023 | msn.com

Azenta Surges, Nearing Breakout, After Ducking Out Of A Looming Proxy Fight

November 14, 2023 | finance.yahoo.com

Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript

November 14, 2023 | benzinga.com

Recap: Azenta Q4 Earnings

November 13, 2023 | msn.com

Azenta makes board changes, takes other steps; avoids proxy fight with activist

November 13, 2023 | finance.yahoo.com

Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

November 13, 2023 | finance.yahoo.com

Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project

November 13, 2023 | finance.yahoo.com

Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation

November 13, 2023 | finance.yahoo.com

Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023

November 10, 2023 | benzinga.com

Azenta's Earnings: A Preview

November 9, 2023 | seekingalpha.com

Azenta: Life Science Play Suffers A Bad Diagnosis

November 8, 2023 | finance.yahoo.com

Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast

October 19, 2023 | finance.yahoo.com

Azenta to Host GENEWIZ Week November 6-10, 2023

September 30, 2023 | msn.com

Activist Politan Capital engages with Azenta. Here’s how the firm may boost shareholder value

September 26, 2023 | seekingalpha.com

Azenta appointed Herman Cueto as new CFO as Robertson retires

September 26, 2023 | finance.yahoo.com

Azenta Announces CFO Transition

September 8, 2023 | finance.yahoo.com

Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

September 7, 2023 | finance.yahoo.com

Azenta to Participate in the Baird 2023 Global Healthcare Conference

September 5, 2023 | finance.yahoo.com

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

August 18, 2023 | thestreet.com

Azenta Inc.

August 15, 2023 | msn.com

Azenta ticks higher amid 13F filing from activist Politan Capital

August 10, 2023 | benzinga.com

Azenta Director Trades $1.05M In Company Stock

August 10, 2023 | finance.yahoo.com

Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023

August 10, 2023 | seekingalpha.com

Azenta, Inc. 2023 Q3 - Results - Earnings Call Presentation

See More Headlines

Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/13/2023
Today: 12/08/2023
Next Earnings (Estimated): 2/14/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Special industry machinery, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AZTA
CUSIP: N/A
CIK: 933974
Web: www.brooks.com
Phone: (978) 262-2400
Fax: 978-262-2500
Employees: 3,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $63.67
High Stock Price Target: $68.00
Low Stock Price Target: $55.00
Potential Upside/Downside: +10.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.18)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 213.33
P/E Growth: N/A
Net Income: $-14,260,000.00
Net Margins: -2.14%
Pretax Margin: -4.58%
Return on Equity: 0.75%
Return on Assets: 0.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.73
Quick Ratio: 6.12

Sales & Book Value

Annual Sales: $665.07 million
Price / Sales: 4.86
Cash Flow: $1.62 per share
Price / Cash Flow: 35.49
Book Value: $42.10 per share
Price / Book: 1.37

Miscellaneous

Outstanding Shares: 56,112,000
Free Float: 55,175,000
Market Cap: $3.23 billion
Optionable: Optionable
Beta: 1.56

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Stephen S. Schwartz (Age 64)
CEO, President & Director
Comp: $1.17M
Mr. Jason W. Joseph (Age 52)
Senior VP, General Counsel & Corporate Secretary
Comp: $651.75k
Ms. Vandana Sriram CPA (Age 49)
Corporate Controller
Comp: $800.2k
Mr. Herman Cueto
Executive VP & CFO
Mr. Robin Vacha (Age 47)
Senior Vice President of Global Operations
Comp: $778.16k
Violetta Hughes
VP & Chief Accounting Officer
Mr. Michael Paulo
VP and Chief Information & Digital Officer
Sara Silverman
Head of Investor Relations & Corporate Communications
Mr. John E. O'Brien (Age 53)
Senior Vice President of Corporate Development
Dr. Claribel Purcell
Senior Vice President of Global Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AZTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Azenta stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AZTA shares.
View AZTA analyst ratings or view top-rated stocks.
What is Azenta's stock price target for 2024?: 4 Wall Street analysts have issued 1 year target prices for Azenta's shares. Their AZTA share price targets range from $55.00 to $68.00. On average, they anticipate the company's share price to reach $63.67 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price.
View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts.
How have AZTA shares performed in 2023?: Azenta's stock was trading at $58.22 at the start of the year. Since then, AZTA stock has decreased by 1.1% and is now trading at $57.60.
View the best growth stocks for 2023 here.
When is Azenta's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our AZTA earnings forecast.
How were Azenta's earnings last quarter?: Azenta, Inc. (NASDAQ:AZTA) released its quarterly earnings data on Monday, November, 13th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.12. The company earned $165.95 million during the quarter, compared to analyst estimates of $163.91 million. Azenta had a negative net margin of 2.14% and a positive trailing twelve-month return on equity of 0.75%. The business's revenue was up 25.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.16 earnings per share.
Is Azenta a good dividend stock?: Azenta (NASDAQ:AZTA) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for AZTA.

What ETFs hold Azenta's stock?: ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), ROBO Global Robotics & Automation ETF (ROBO), Harbor Health Care ETF (MEDI) and Principal Healthcare Innovators ETF (BTEC).BlackRock Future Innovators ETF (BFTR).
What guidance has Azenta issued on next quarter's earnings?: Azenta updated its FY 2024 earnings guidance on Monday, November, 13th. The company provided earnings per share guidance of $0.19-$0.29 for the period, compared to the consensus earnings per share estimate of $0.22. The company issued revenue guidance of $696.00 million-$718.00 million, compared to the consensus revenue estimate of $705.60 million.
Who are Azenta's major shareholders?: Azenta's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (7.53%), Allspring Global Investments Holdings LLC (3.02%), Teacher Retirement System of Texas (1.91%), Conestoga Capital Advisors LLC (1.89%), JPMorgan Chase & Co. (1.85%) and Morgan Stanley (1.78%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends.
How do I buy shares of Azenta?: Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Azenta Stock Price, News & Analysis (NASDAQ:AZTA)

Azenta MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Azenta Stock (NASDAQ:AZTA)

AZTA Stock Price History

AZTA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AZTA Stock Analysis - Frequently Asked Questions

Overall MarketRank^™